¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"exposure keratopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼¹°Áý°¢¸·º´(Áõ), ¹«¼öÁ¤Ã¼¼öÆ÷°¢¸·º´(Áõ)
  • actinic keratopathy
    ±¤¼±°¢¸·º´(Áõ), ±¤È­Çа¢¸·º´(Áõ)
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´(Áõ), ´ë»ó°¢¸·º´(Áõ)
  • bullous keratopathy
    ¹°Áý°¢¸·º´(Áõ), ¼öÆ÷°¢¸·º´(Áõ)
  • filamentary keratopathy
    ½Ç¸ð¾ç°¢¸·º´(Áõ), »ç»ó°¢¸·º´(Áõ)
  • keratopathy
    °¢¸·º´(Áõ)
  • neuroparalytic keratopathy
    ½Å°æ¸¶ºñ°¢¸·º´(Áõ)
  • pseudophakic bullous keratopathy
    Àΰø¼öÁ¤Ã¼¹°Áý°¢¸·º´(Áõ), Àΰø¼öÁ¤Ã¼¼öÆ÷°¢¸·º´(Áõ)
  • punctate keratopathy
    Á¡¸ð¾ç°¢¸·º´(Áõ), Á¡»ó°¢¸·º´(Áõ)
  • striate keratopathy
    ÁÙ¹«´Ì°¢¸·º´(Áõ), ¼±»ó°¢¸·º´(Áõ)
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • chronic exposure
    ¸¸¼º³ëÃâ
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ(¼ú)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • keratopathy
    °¢¸·º´Áõ
  • exposure
    ³ëÃâ
  • occupational exposure
    Á÷¾÷³ëÃâ
  • public exposure
    °øÁßÇÇÆø, °øÁß³ëÃâ
  • radiation exposure
    ¹æ»ç¼±³ëÃâ
  • sun exposure
    Àϱ¤³ëÃâ
  • exposure time
    ³ëÃâ½Ã°£, Æø·Î½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • actinic keratopathy
    ±¤¼±°¢¸·º´Áõ
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼¹°Áý°¢¸·º´Áõ
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ
  • bullous keratopathy
    ¹°Áý°¢¸·º´Áõ
  • filamentary keratopathy
    ½Ç¸ð¾ç°¢¸·º´Áõ
  • keratopathy
    °¢¸·º´Áõ
  • neuroparalytic keratopathy
    ½Å°æ¸¶ºñ°¢¸·º´Áõ
  • pseudophakic bullous keratopathy
    Àΰø¼öÁ¤Ã¼¹°Áý°¢¸·º´Áõ
  • punctate keratopathy
    Á¡»ó°¢¸·º´Áõ
  • striate keratopathy
    ÁÙ¹«´Ì°¢¸·º´Áõ
  • accidental exposure
    »ç°íÇÇÆø, »ç°í³ëÃâ
  • acute exposure
    ±Þ¼ºÇÇÆø, ±Þ¼º³ëÃâ
  • chronic exposure
    ¸¸¼ºÇÇÆø, ¸¸¼º³ëÃâ
  • cumulative glycemic exposure
    ´©Àû°íÇ÷´ç³ëÃâ
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • actinic keratopathy
    ±¤È­Çа¢¸·º´Áõ
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼¼öÆ÷°¢¸·º´Áõ
  • punctate keratopathy
    Á¡»ó°¢¸·º´Áõ
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
  • prolonged exposure
    Àå±â³ëÃâ.
  • public exposure
    °øÁßÇÇÆø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure keratopathy
    ³ëÃâ°¢¸·º´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • actinic keratopathy
    ±¤È­Çа¢¸·º´Áõ
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼¼öÆ÷°¢¸·º´Áõ
  • band keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ, ´ë»ó°¢¸·º´Áõ(¡­Ü»ñø)
  • band-shaped keratopathy
    ¶ì¸ð¾ç°¢¸·º´Áõ, ´ë»ó°¢¸·º´Áõ
  • bullous keratopathy
    ¼öÆ÷°¢¸·º´Áõ
  • filamentary keratopathy
    ½Ç¸ð¾ç°¢¸·º´Áõ, »ç»ó°¢¸·º´Áõ
  • keratopathy
    °¢¸·º´Áõ
  • lipid keratopathy
    ÁöÁú°¢¸·º´Áõ
  • neuroparalytic keratopathy
    ½Å°æ¸¶ºñ°¢¸·º´Áõ
  • pseudophakic bullous keratopathy
    Àΰø¼öÁ¤Ã¼¼öÆ÷°¢¸·º´Áõ
  • punctate keratopathy
    Á¡»ó°¢¸·º´Áõ
  • striate keratopathy
    ¼±»ó°¢¸·º´Áõ
  • superficial punctate keratopathy
    Ç¥ÃþÁ¡»ó°¢¸·º´Áõ
  • accidental exposure
    »ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
  • acute exposure
    ±Þ¼ºÇÇÆø
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure dose
    ³ëÃâ·®(ÖÚõóÕá)
  • gaseous exposure method
    °³½º ³ëÃâ¹ý(ÖÚõóÛö)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • double exposure technique
    Áߺ¹X¼±ÃÔ¿µ¼ú
  • exposure
    ³ëÃâ, Æø·Î, Á¶»ç
  • exposure time
    ³ëÃâ½Ã°£, Á¶ ½Ã°£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABK aphakic bullous keratopathy
CDK cell division kinase; climatic droplet keratopathy; cyclin-dependent kinase
ABCDE airway, breathing, circulation, disability, exposure [in trauma patients]; botulism toxin pentavalen...
ALARA as low as reasonably achievable [radiation exposure]
BEI back-scattered electron imaging; biological exposure indexes; butanol-extractable iodine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PBK Pseudophakic Bullous Keratopathy
AEC Automatic Exposure Control
B.E.I. Biological Exposure Index
FAE Fetal alcohol exposure
JEM Job Exposure Matrix
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aphakic bullous keratopathy
    ¹«¼öÁ¤Ã¼ ¼öÆ÷ °¢¸·º´Áõ
  • band keratopathy
    ´ë»ó °¢¸·Áõ, ¶ì ¸ð¾ç °¢¸·º´Áõ, ´ë»ó °¢¸·º´Áõ
    °Ë¿­¿¡ »ó´çÇÏ´Â ºÎºÐÀÇ °¢¸·¿¡ ´ë»óÀÇ È¸¹é»ö ȥŹÀÌ »ý±â´Â °ÍÀ¸·Î¼­, ȥŹÀÇ ºÎÀ§´Â Bowman¸· ºÎ±Ù.
  • band-shaped keratopathy
    ¶ì ¸ð¾ç °¢¸·º´Áõ, ´ë»ó °¢¸· º´Áõ
  • pseudophakic bullous keratopathy
    Àΰø ¼öÁ¤Ã¼ ¼öÆ÷ °¢¸·º´Áõ
  • acute exposure
    ±Þ¼º ÇÇÆø
    ¹æ»ç¼± °Ç°­°ü¸®Çлó »ç¿ëµÇ´Â ¿ë¾îÀÌ°í ¹æ»ç¼± »ç°í µî, ºñ±³Àû ªÀº ½Ã°£¿¡ °íü°¡ ÇÇÆøÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. Á÷¾÷ÀûÀ¸·Î ¾Æ¹«·¡µµ ÇÇÇÒ ¼ö ¾ø´Â ÇÇÆøÀ̳ª ½ºÆ®·ÐƬÀÇ »À¿¡ ´ëÇÑ Ä§Âø µî Àå¹Ý°¨±âÀÇ ¹æ»ç¼± µ¿À§¿ø¼Ò°¡ ¸ö ¾È¿¡ µé¾î°£ °æ¿ìÀÇ ÇÇÆøÀ» ¸¸¼º ÇÇÆøÀ̶ó°í ¸»Çϴµ¥ ´ëÇØ¼­ À̰°ÀÌ ¸»ÇÑ´Ù.
  • chemical exposure
    È­ÇÐÀû ³ëÃâ
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • double exposure technique
    Áߺ¹ X¼± ÃÔ¿µ¼ú
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • exposure dose
    Á¶»ç·®
  • exposure threshold
    ³ëÃâ ÇѰèÄ¡
  • exposure time per session
    ´ÜÀ§´ç ³ëÃ⠽ð£
  • long-term exposure
    Àå±â ³ëÃâ
  • maximum permissible exposure
    ÃÖ´ë Çã¿ë ³ëÃâ
  • mercury exposure
    ¼öÀº¿¡ÀÇ ³ëÃâ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
band-shaped keratopathy A horizontal, gray, interpalpebral opacity of the cornea that begins at the periphery and progresses centrally; occurs in hypercalcaemia, chronic iridocyclitis, and Still's disease.
(05 Mar 2000)
bullous keratopathy Oedema of the corneal stroma and epithelium; occurs in Fuchs' epithelial dystrophy, advanced glaucoma and iridocyclitis, and sometimes after intraocular lens implantation.
(05 Mar 2000)
vesicular keratopathy Corneal epithelial oedema with formation of vacuoles.
(05 Mar 2000)
climatic keratopathy A bilateral, symmetrical corneal dystrophy caused by prolonged exposure to extremes of heat or cold; nodular opacities are limited to the interpalpebral area and vision is only mildly affected.
Synonym: Labrador keratopathy.
(05 Mar 2000)
neuroparalytic keratopathy Corneal inflammation or ulceration associated with dysfunction of the ophthalmic branch of the trigeminal nerve.
(05 Mar 2000)
striate keratopathy Corneal stromal oedema with formation of criss-cross tracts.
(05 Mar 2000)
keratopathy Any corneal disease, damage, dysfunction, or abnormality.
Origin: kerato-+ G. Pathos, suffering, disease
(05 Mar 2000)
filamentary keratopathy Formation of fine elongations of corneal epithelium in inflammation, oedema, and degenerative states.
(05 Mar 2000)
Labrador keratopathy A bilateral, symmetrical corneal dystrophy caused by prolonged exposure to extremes of heat or cold; nodular opacities are limited to the interpalpebral area and vision is only mildly affected.
Synonym: Labrador keratopathy.
(05 Mar 2000)
lipid keratopathy Occurrence of fats in an area of corneal vascularization.
(05 Mar 2000)
maternal exposure Exposure of the female parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring. It includes pre-conception maternal exposure.
(12 Dec 1998)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
paternal exposure Exposure of the male parent, human or animal, to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals that may affect offspring.
(12 Dec 1998)
permissible exposure limit An occupational health standard to safeguard workers against dangerous contaminants in the workplace.
(05 Mar 2000)
prenatal exposure delayed effects Delayed effects on offspring of maternal or foetal prenatal exposure to drugs, radiation and other physical agents, manipulation, nutrition, stress, etc.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • exposure
    ³ëÃâ
  • double exposure
    (»ç)ÀÌÁß ³ëÃâ
  • exposure
    ¹ö·ÁµÒ;(Áý,¹æÀÇ)Çâ;³ëÃâ;Æø·Î;Àû¹ß;(¾î¸°¾ÖÀÇ)À¯±â
  • exposure index
    ³ë±¤Áö¼ö
  • exposure meter
    ³ëÃâ°è
  • indecent exposure
    (¹ý)°ø°³Àû ¿Ü¼³ÁË
  • time exposure
    ŸÀÓ ³ëÃâ(ÀÇ »çÁø)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á